Find clinical trials for COVID-19 in Detroit, MI
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
COVID-19 trials near Detroit, MI, USA:
IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who a...
Phase 3
Detroit, Michigan, United States and 158 other locations
The main purpose of this study is to test an investigational drug known as VYD2311, which is being developed to lower the risk of getting COVID...
Phase 3
Southfield, Michigan, United States and 19 other locations
condition that puts them at increased risk for severe outcomes of COVID-19 and who have been previously vaccinated with a COVID...
Phase 4
Southfield, Michigan, United States and 19 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
Dearborn, Michigan, United States and 227 other locations
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...
Phase 3
Dearborn, Michigan, United States and 262 other locations
The purpose of this study is to learn about the safety and effects of the vaccine (called COMIRNATY) for the potential prevention of COVID-19...
Phase 4
Detroit, Michigan, United States and 17 other locations
the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...
Phase 4
Southfield, Michigan, United States and 149 other locations
This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...
Phase 2, Phase 3
Grosse Pointe Woods, Michigan, United States and 91 other locations
A Phase 2a, randomized, double-blind, placebo-controlled, multiple ascending dose study in patients who are hospitalized with presumed pneumonia requ...
Phase 2
Detroit, Michigan, United States and 7 other locations
This study will evaluate 2 dose levels of mRNA-1283 in participants ≥6 months to \<12 years to determine the optimal dose level per age group.
Phase 2
Southfield, Michigan, United States and 30 other locations
Clinical trials
Research sites
Resources
Legal